annual CFO:
$8.38B-$45.33M(-0.54%)Summary
- As of today (May 21, 2025), GSK annual cash flow from operations is $8.38 billion, with the most recent change of -$45.33 million (-0.54%) on December 31, 2024.
- During the last 3 years, GSK annual CFO has fallen by -$2.56 billion (-23.43%).
- GSK annual CFO is now -37.14% below its all-time high of $13.32 billion, reached on December 31, 2008.
Performance
GSK Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$1.44B-$1.44B(-49.92%)Summary
- As of today (May 21, 2025), GSK quarterly cash flow from operations is $1.44 billion, with the most recent change of -$1.44 billion (-49.92%) on March 31, 2025.
- Over the past year, GSK quarterly CFO has increased by +$226.60 million (+18.65%).
- GSK quarterly CFO is now -74.40% below its all-time high of $5.63 billion, reached on December 31, 2018.
Performance
GSK quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$8.60B+$226.60M(+2.71%)Summary
- As of today (May 21, 2025), GSK TTM cash flow from operations is $8.60 billion, with the most recent change of +$226.60 million (+2.71%) on March 31, 2025.
- Over the past year, GSK TTM CFO has dropped by -$969.43 million (-10.13%).
- GSK TTM CFO is now -38.21% below its all-time high of $13.92 billion, reached on June 30, 2022.
Performance
GSK TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GSK Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.5% | +18.6% | -10.1% |
| 3 y3 years | -23.4% | -57.7% | -38.1% |
| 5 y5 years | -18.2% | +16.6% | -18.9% |
GSK Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -23.4% | at low | -63.0% | +2137.9% | -38.2% | +53.1% |
| 5 y | 5-year | -23.4% | at low | -72.1% | +2137.9% | -38.2% | +53.1% |
| alltime | all time | -37.1% | +1132.6% | -74.4% | +134.2% | -38.2% | +349.1% |
GSK Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.44B(-49.9%) | $8.60B(+2.7%) |
| Dec 2024 | $8.38B(-0.5%) | $2.88B(-0.2%) | $8.38B(-10.9%) |
| Sep 2024 | - | $2.88B(+106.4%) | $9.40B(+0.7%) |
| Jun 2024 | - | $1.40B(+15.0%) | $9.33B(-2.5%) |
| Mar 2024 | - | $1.22B(-68.8%) | $9.57B(+13.7%) |
| Dec 2023 | $8.42B(-8.1%) | $3.90B(+38.2%) | $8.42B(+16.6%) |
| Sep 2023 | - | $2.82B(+72.2%) | $7.22B(+28.5%) |
| Jun 2023 | - | $1.64B(+2442.4%) | $5.62B(-3.5%) |
| Mar 2023 | - | $64.42M(-97.6%) | $5.82B(-36.5%) |
| Dec 2022 | $9.17B(-16.2%) | $2.70B(+121.1%) | $9.17B(-21.2%) |
| Sep 2022 | - | $1.22B(-33.7%) | $11.64B(-16.4%) |
| Jun 2022 | - | $1.84B(-46.0%) | $13.92B(+0.2%) |
| Mar 2022 | - | $3.41B(-34.0%) | $13.89B(+27.0%) |
| Dec 2021 | $10.94B(+1.0%) | $5.17B(+47.6%) | $10.94B(+2.5%) |
| Sep 2021 | - | $3.50B(+93.2%) | $10.68B(+25.9%) |
| Jun 2021 | - | $1.81B(+297.2%) | $8.48B(-15.6%) |
| Mar 2021 | - | $456.28M(-90.7%) | $10.05B(-7.2%) |
| Dec 2020 | $10.83B(+5.8%) | $4.91B(+275.5%) | $10.83B(+2.8%) |
| Sep 2020 | - | $1.31B(-61.4%) | $10.54B(-13.8%) |
| Jun 2020 | - | $3.38B(+173.5%) | $12.22B(+15.2%) |
| Mar 2020 | - | $1.24B(-73.2%) | $10.61B(+3.6%) |
| Dec 2019 | $10.24B(-8.9%) | $4.61B(+54.3%) | $10.24B(-9.0%) |
| Sep 2019 | - | $2.99B(+68.6%) | $11.26B(+3.9%) |
| Jun 2019 | - | $1.77B(+105.3%) | $10.84B(-0.5%) |
| Mar 2019 | - | $863.72M(-84.7%) | $10.90B(-3.0%) |
| Dec 2018 | $11.24B(+25.8%) | $5.63B(+119.0%) | $11.24B(+21.7%) |
| Sep 2018 | - | $2.57B(+40.4%) | $9.24B(+0.2%) |
| Jun 2018 | - | $1.83B(+52.7%) | $9.21B(+5.7%) |
| Mar 2018 | - | $1.20B(-67.0%) | $8.72B(-2.4%) |
| Dec 2017 | $8.93B(+1.5%) | $3.63B(+42.5%) | $8.93B(-6.0%) |
| Sep 2017 | - | $2.55B(+91.1%) | $9.50B(+4.9%) |
| Jun 2017 | - | $1.33B(-5.8%) | $9.06B(-4.7%) |
| Mar 2017 | - | $1.42B(-66.2%) | $9.50B(+7.9%) |
| Dec 2016 | $8.80B(+124.2%) | $4.20B(+99.2%) | $8.80B(+28.0%) |
| Sep 2016 | - | $2.11B(+18.5%) | $6.88B(+24.5%) |
| Jun 2016 | - | $1.78B(+146.9%) | $5.52B(+35.2%) |
| Mar 2016 | - | $720.05M(-68.3%) | $4.09B(+4.1%) |
| Dec 2015 | $3.93B(-54.0%) | $2.27B(+200.5%) | $3.93B(-25.0%) |
| Sep 2015 | - | $755.80M(+123.4%) | $5.24B(-20.5%) |
| Jun 2015 | - | $338.30M(-39.7%) | $6.58B(-12.9%) |
| Mar 2015 | - | $560.83M(-84.3%) | $7.56B(-11.4%) |
| Dec 2014 | $8.53B(-24.5%) | $3.58B(+70.3%) | $8.53B(+1.0%) |
| Sep 2014 | - | $2.10B(+59.9%) | $8.44B(-12.1%) |
| Jun 2014 | - | $1.32B(-14.2%) | $9.60B(-11.8%) |
| Mar 2014 | - | $1.53B(-56.1%) | $10.90B(-3.6%) |
| Dec 2013 | $11.30B(+63.0%) | $3.49B(+7.0%) | $11.30B(+4.1%) |
| Sep 2013 | - | $3.26B(+25.2%) | $10.85B(+52.4%) |
| Jun 2013 | - | $2.61B(+34.6%) | $7.12B(-2.1%) |
| Mar 2013 | - | $1.94B(-36.4%) | $7.28B(+5.0%) |
| Dec 2012 | $6.93B(-30.8%) | $3.05B(-754.1%) | $6.93B(-5.0%) |
| Sep 2012 | - | -$465.79M(-116.9%) | $7.30B(-31.5%) |
| Jun 2012 | - | $2.76B(+73.8%) | $10.66B(+6.3%) |
| Mar 2012 | - | $1.59B(-53.4%) | $10.03B(+0.1%) |
| Dec 2011 | $10.02B | $3.41B(+17.9%) | $10.02B(+13.5%) |
| Sep 2011 | - | $2.90B(+35.8%) | $8.83B(+12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | $2.13B(+34.8%) | $7.87B(-10.0%) |
| Mar 2011 | - | $1.58B(-28.7%) | $8.75B(-16.5%) |
| Dec 2010 | $10.48B(-14.7%) | $2.22B(+14.2%) | $10.48B(-8.0%) |
| Sep 2010 | - | $1.94B(-35.4%) | $11.39B(-13.5%) |
| Jun 2010 | - | $3.01B(-9.1%) | $13.16B(+0.5%) |
| Mar 2010 | - | $3.31B(+5.7%) | $13.10B(+6.6%) |
| Dec 2009 | $12.28B(-7.8%) | $3.13B(-15.8%) | $12.28B(-4.8%) |
| Sep 2009 | - | $3.72B(+26.4%) | $12.90B(+3.2%) |
| Jun 2009 | - | $2.94B(+17.9%) | $12.50B(+2.0%) |
| Mar 2009 | - | $2.49B(-33.4%) | $12.26B(-8.0%) |
| Dec 2008 | $13.32B(+8.0%) | $3.75B(+12.8%) | $13.32B(+8.6%) |
| Sep 2008 | - | $3.32B(+23.1%) | $12.27B(-6.4%) |
| Jun 2008 | - | $2.70B(-24.3%) | $13.11B(+1.5%) |
| Mar 2008 | - | $3.56B(+32.6%) | $12.91B(+4.6%) |
| Dec 2007 | $12.34B(+53.7%) | $2.69B(-35.4%) | $12.34B(-3.4%) |
| Sep 2007 | - | $4.16B(+66.2%) | $12.78B(+55.6%) |
| Jun 2007 | - | $2.50B(-16.3%) | $8.21B(+3.9%) |
| Mar 2007 | - | $2.99B(-4.2%) | $7.90B(-1.6%) |
| Dec 2006 | $8.03B(-25.9%) | $3.12B(-873.8%) | $8.03B(+0.2%) |
| Sep 2006 | - | -$403.30M(-118.4%) | $8.01B(-26.7%) |
| Jun 2006 | - | $2.19B(-29.7%) | $10.93B(-6.6%) |
| Mar 2006 | - | $3.12B(+0.6%) | $11.70B(+8.0%) |
| Dec 2005 | $10.84B(+19.7%) | $3.10B(+23.2%) | $10.84B(+14.0%) |
| Sep 2005 | - | $2.52B(-15.1%) | $9.50B(+9.9%) |
| Jun 2005 | - | $2.97B(+31.6%) | $8.65B(-2.4%) |
| Mar 2005 | - | $2.25B(+27.5%) | $8.86B(-2.1%) |
| Dec 2004 | $9.06B(+14.2%) | $1.77B(+6.4%) | $9.06B(+49.7%) |
| Sep 2004 | - | $1.66B(-47.8%) | $6.05B(-25.5%) |
| Jun 2004 | - | $3.18B(+30.0%) | $8.12B(-6.2%) |
| Mar 2004 | - | $2.45B(-297.5%) | $8.66B(+9.2%) |
| Dec 2003 | $7.93B(+72.5%) | -$1.24B(-133.2%) | $7.93B(+60.2%) |
| Sep 2003 | - | $3.74B(+0.4%) | $4.95B(+2.2%) |
| Jun 2003 | - | $3.72B(+116.5%) | $4.85B(+14.0%) |
| Mar 2003 | - | $1.72B(-140.7%) | $4.25B(-7.6%) |
| Dec 2002 | $4.60B(-30.7%) | -$4.22B(-216.3%) | $4.60B(-47.4%) |
| Sep 2002 | - | $3.63B(+16.1%) | $8.74B(+14.9%) |
| Jun 2002 | - | $3.12B(+51.2%) | $7.61B(+6.0%) |
| Mar 2002 | - | $2.07B(-2731.1%) | $7.18B(+8.1%) |
| Dec 2001 | $6.64B(+136.5%) | -$78.55M(-103.2%) | $6.64B(+66.5%) |
| Sep 2001 | - | $2.49B(-7.6%) | $3.99B(-18.9%) |
| Jun 2001 | - | $2.70B(+76.6%) | $4.92B(+103.2%) |
| Mar 2001 | - | $1.53B(-156.0%) | $2.42B(-13.8%) |
| Dec 2000 | $2.81B(+240.2%) | -$2.73B(-179.8%) | $2.81B(-49.3%) |
| Sep 2000 | - | $3.42B(+1599.9%) | $5.54B(+161.6%) |
| Jun 2000 | - | $201.19M(-89.5%) | $2.12B(+10.5%) |
| Mar 2000 | - | $1.92B | $1.92B |
| Dec 1999 | $825.24M(+21.4%) | - | - |
| Dec 1998 | $679.54M(-32.6%) | - | - |
| Dec 1997 | $1.01B(-24.0%) | - | - |
| Dec 1996 | $1.33B(-32.9%) | - | - |
| Dec 1995 | $1.98B(-48.9%) | - | - |
| Jun 1995 | $3.87B(+145.2%) | - | - |
| Jun 1994 | $1.58B(+4.6%) | - | - |
| Jun 1993 | $1.51B(+30.4%) | - | - |
| Jun 1992 | $1.16B(+1.3%) | - | - |
| Jun 1991 | $1.14B | - | - |
FAQ
- What is GSK annual cash flow from operations?
- What is the all time high annual CFO for GSK?
- What is GSK annual CFO year-on-year change?
- What is GSK quarterly cash flow from operations?
- What is the all time high quarterly CFO for GSK?
- What is GSK quarterly CFO year-on-year change?
- What is GSK TTM cash flow from operations?
- What is the all time high TTM CFO for GSK?
- What is GSK TTM CFO year-on-year change?
What is GSK annual cash flow from operations?
The current annual CFO of GSK is $8.38B
What is the all time high annual CFO for GSK?
GSK all-time high annual cash flow from operations is $13.32B
What is GSK annual CFO year-on-year change?
Over the past year, GSK annual cash flow from operations has changed by -$45.33M (-0.54%)
What is GSK quarterly cash flow from operations?
The current quarterly CFO of GSK is $1.44B
What is the all time high quarterly CFO for GSK?
GSK all-time high quarterly cash flow from operations is $5.63B
What is GSK quarterly CFO year-on-year change?
Over the past year, GSK quarterly cash flow from operations has changed by +$226.60M (+18.65%)
What is GSK TTM cash flow from operations?
The current TTM CFO of GSK is $8.60B
What is the all time high TTM CFO for GSK?
GSK all-time high TTM cash flow from operations is $13.92B
What is GSK TTM CFO year-on-year change?
Over the past year, GSK TTM cash flow from operations has changed by -$969.43M (-10.13%)